STOCK TITAN

Polyrizon Ltd SEC Filings

PLRZ NASDAQ

Welcome to our dedicated page for Polyrizon SEC filings (Ticker: PLRZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Polyrizon’s SEC reports routinely span hundreds of pages packed with clinical trial data, patent milestones, and cash-runway forecasts—critical details that can overwhelm even seasoned biotech investors. Missing a single footnote on R&D obligations or a late-night 8-K material event could mean overlooking a pivotal inflection point.

Stock Titan solves that pain. Our AI digests every 10-K annual report, 10-Q quarterly earnings report, and registration statement, translating technical language about intranasal hydrogel science into clear insights. Want to spot dilution risks before they happen? Our algorithms flag shelf offerings the moment they appear. Need "Polyrizon insider trading Form 4 transactions"? We stream Form 4 filings in real time, highlighting executive stock moves so you always know who is buying or selling. Search traffic naturally lands here for phrases such as "understanding Polyrizon SEC documents with AI" or "Polyrizon earnings report filing analysis"—because we answer those questions directly.

Beyond raw documents, you’ll find:

  • Side-by-side AI summaries that explain clinical-stage burn rates in the Polyrizon annual report 10-K simplified
  • Immediate alerts on Polyrizon Form 4 insider transactions real-time, including option grants tied to milestone achievements
  • Concise breakdowns of patent-portfolio disclosures in each Polyrizon 8-K material events explained filing
  • Clear tables connecting proxy data to "Polyrizon proxy statement executive compensation" so you can benchmark leadership incentives

Every document, from S-1 shelf registrations to complex merger exhibits, is indexed and updated as soon as EDGAR releases them. With Stock Titan’s expert analysis, biotech intricacy becomes readable context—empowering you to make confident, timely decisions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.89%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
59.73%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
52.47%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Polyrizon (PLRZ)?

The current stock price of Polyrizon (PLRZ) is $1.02 as of September 5, 2025.

What is the market cap of Polyrizon (PLRZ)?

The market cap of Polyrizon (PLRZ) is approximately 6.4M.
Polyrizon Ltd

NASDAQ:PLRZ

PLRZ Rankings

PLRZ Stock Data

6.41M
5.99M
0.01%
6.19%
4.88%
Biotechnology
Healthcare
Link
Israel
Ra'anana